TheJobsMapOncoPep jobs and careers
Boston, MA, United States
About OncoPep
Through targeting multiple tumor-associated antigens with an investigational multi-peptide vaccine and a multi-tumor antigen adoptive (MTAA) T cell therapy, OncoPep’s T cell-focused technologies are designed to be used on their own or in combination with other immunotherapeutics.
Founded in 2010 by Ken Anderson and Marc Cohen.
- Founded
- 2010
- Employees
- 11 to 50
- Total funding
- $28.4M
- Headquarters
- Boston
Leadership
The top of OncoPep's org chart, with how many people report into each leader.
Arthur Becker
CEO
6 reports
Tina Soulis
Director, Australia
3 reports
Doris Peterkin
Head, Vaccine Development
1 report
Board
Bruce Downey
Board Member
Kenneth C. Anderson
Scientific Advisor
James Mulé
Scientific Advisor
Jooeun Bae
Advisor
Nikhil C. Munshi
Scientific Advisor
Jay Eastman
Board Member
Jobs at OncoPep
No open positions right now. Explore more companies on TheJobsMap.